Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT

v3.20.1
STOCKHOLDERS' DEFICIT
3 Months Ended
Mar. 31, 2020
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' DEFICIT

NOTE 9 – STOCKHOLDERS’ DEFICIT


During the three months ended March 31, 2020, no shares were issued.  The Company received $416,667 from investors in exchange for 4,166,667 restricted common shares, par value $.001 per share, for $0.10 per share and 4,000,000 five-year warrants with a strike price of $0.30 per share and 16,667 five-year warrants with a strike price of $0.40 per share. The $416,667 is reflected as a subscription liability on the Company’s condensed consolidated balance sheet as of March 31, 2020. The shares were subsequently issued to investors on April 1, 2020 and April 13, 2020 as discussed in Note 12.